http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H09501162-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-1804 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-18 |
| filingDate | 1994-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1997-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H09501162-A |
| titleOfInvention | Activated macrolactam with immunomodulatory activity |
| abstract | (57) [Summary] Having immunomodulatory activity and having the formula (I), wherein n is zero or 1, and R 101 is selected from the group consisting of methyl, ethyl, allyl, propyl and cyclopropylmethyl. R 102 is hydrogen and R 103 is selected from the group consisting of hydrogen, hydroxy and protected hydroxy groups, or R 102 and R 103 taken together form a bond, R 104 and R 105 Are selected such that if one is hydrogen, the other is -OS (O) 2 F, and R 106 is selected from the group consisting of hydrogen, a protected hydroxy group, lower alkyl, alkenyl, cycloalkyl, aryl and arylalkyl. And a method for producing the compound, and the use of the compound in the production of a C-32 modified derivative of ascomycin or a homologue or analog thereof. Usage. |
| priorityDate | 1993-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 91.